A cross-section of UK prostate cancer diagnostics during the COVID-19 era - a shifting paradigm?

Abstract The prostate cancer diagnostic pathway accounts for over 50,000 prostate biopsies each year (1) In an attempt to minimise the transmission of the COVID-19 virus, during the height of the COVID-19 many outpatient and procedural attendances were kept to a minimum in an attempt to safeguard patients and healthcare workers alike